FDA recall record
Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets
FDA classification. FDA Class I, II, and III are not the same as USDA FSIS classifications and are not a cross-agency safety score.
FDA listed a termination date of August 22, 2017. openFDA does not treat this as a live recall-status tracker.
Product described in an FDA recall
Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets
Reason
Nu Skin announces a voluntary field action for Pharmanex BioGinkgo due to undeclared allergen; wheat.
Products involved
Product descriptions are copied from the FDA recall record. They are not a current catalog and are not automatically matched to WhoMadeMyFood product pages.
Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets
Code information listed by FDA
Batches: DL14951-07, DL31551-07, DL21161-07
Distribution and firm information
Recalling firm listed by FDA: Nu Skin Enterprises Inc.
Firm location listed by FDA: Provo, UT, United States
Distribution reported by FDA: Nationwide, Canadian and other foreign consignees. No VA/govt/military consignees.
Product quantity listed by FDA: 40,158
Source
Source: U.S. Food and Drug Administration (FDA), openFDA food enforcement reports.
Official FDA openFDA food enforcement record
Identifying an FDA recall record does not imply FDA endorsement of WhoMadeMyFood. Methodology.